Cholangiocarcinoma and liver transplantation: What we know so far?

doi:10.4291/wjgp.v12.i5.84

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7207)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

307

WORD

HTML

3286

Figures (1-1)

332

Tables (1-5)

386

Sum=4409

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

360

Download

907

Sum=1267

Publishing Process of This Article

Item

Count

Browse

493

Download

1038

Sum=1531

Sep 22, 2021 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pathophysiol. Sep 22, 2021; 12(5): 84-105
Published online Sep 22, 2021. doi: 10.4291/wjgp.v12.i5.84

Full Size Figure Download Figure

Figure 1 Major signalling pathways involved in cholangiocarcinoma. The major signaling pathways involved in cholangiocarcinomas could be categorized into three main class: (1) Microenvironment and inflammation-related pathways; (2) Pathways related to proliferation/survival/death; and (3) Development-related pathways. TGF-β: Transforming growth factor-β; CCA: Cholangiocarcinoma; IL: Interleukin; FGFR2: Fibroblast growth factor receptor 2; PI3K: Phosphatidylinositol 3 kinase; ERK: Extracellular signal-regulated kinase; JAK/STAT: Janus kinase and signal transducer and activator of transcription.

Citation: Safarpour AR, Askari H, Ejtehadi F, Azarnezhad A, Raeis-Abdollahi E, Tajbakhsh A, Abazari MF, Tarkesh F, Shamsaeefar A, Niknam R, Sivandzadeh GR, Lankarani KB, Ejtehadi F. Cholangiocarcinoma and liver transplantation: What we know so far? World J Gastrointest Pathophysiol 2021; 12(5): 84-105
URL: https://www.wjgnet.com/2150-5330/full/v12/i5/84.htm
DOI: https://dx.doi.org/10.4291/wjgp.v12.i5.84